Published • loading... • Updated
Novo Nordisk "Very Surprised" by Dieting-No
Summary by Dagens Industri
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Novo Nordisk has once again applied for the company's drug Wegovy to be included in the drug benefit for the treatment of obesity in children. However, the Swedish Dental and Pharmaceutical Agency (TLV) has determined that the application cannot be considered. The reason is a previous appeal from the company to the court, writes Di's sister newspaper Dagens Medicin.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
